Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
SAGAPHARM from Héron, company number BE0748644218, closed financial year 2025 with a result of € -19,557 after tax. For that financial year SAGAPHARM recorded a gross margin of € 192,667 and equity of € 196,807. Compared with financial year 2024, the result moved from € -76,029 to € -19,557. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.
€ 196,807
▲ € 295,243 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -19,557
▲ 74 % less loss than in 2024
Profit after tax over the fiscal year.
€ 10,405
▼ 68% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -137,993.
Debts at end 2025
€ 1.8 million
▼ 17% vs 2024
€ 60,358 is repaid this year. At this pace the long-term loan is gone in ≈ 30 years.
€ 5,624
▼ 58% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,496
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 20,543 | € 39,635 | € 137,238 | € 192,667 | ▲ 40% |
| Profit after taxes | € 3,746 | € -44,351 | € -76,029 | € -19,557 | ▲ € 56,472 |
| Equity | € 21,944 | € -22,407 | € -98,436 | € 196,807 | ▲ € 295,243 |
| Total debts | € 229,975 | € 2,255,622 | € 2,283,003 | € 1,989,657 | ▼ 13% |
| Cash | € 1,081 | € 138,966 | € 32,212 | € 10,405 | ▼ 68% |
| Land & buildings | € 211,586 | € 2,050,907 | € 2,103,216 | € 2,083,624 | ▼ 1% |
| Retained profit | € 1,944 | € -42,407 | € -118,436 | € -137,993 | ▼ € 19,557 |
| Bank debt | € 204,662 | € 2,156,791 | € 2,148,785 | € 1,788,480 | ▼ 17% |
| Balance sheet total | € 251,919 | € 2,233,214 | € 2,184,567 | € 2,186,464 |
Key figures of SAGAPHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SAGAPHARM?
What happened at SAGAPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 19,557. filed late Source: NBB ↗
- New establishment in Héron. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,746 profit in 2022 to € 19,557 loss in 2025.
Paid € 2,135 in corporate taxes since 2022.
Best year ever: 2022, with € 3,746 profit.
Establishments
Establishment units
Physical locations of this company
Rue de la Gare 10
4217 Héron
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0748.644.218
- VAT number
- BE 0748.644.218
- Registered office
- Rue de la Gare 10, 4217 Héron
- Names & denominations
- SAGAPHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 June 2020
- Peppol
- Active · Active since 5 Feb 2026
- Activities · NACE
Handel in eigen onroerend goed
Activiteiten van syndici van onroerend goed
Plaatsen van behang en vloerbedekking en wandbekleding van andere materialen
Stukadoorswerk
Schilderen van gebouwen
Diverse ondersteunende activiteiten ten behoeve van voorzieningen
Algemene elektrotechnische installatiewerken
Algemene reiniging van gebouwen
+4